Acerus Pharma Cash Flow - Annual (OTCMKTS:TRLPF)

Add to My Stocks
$0.21 $0 (0%) TRLPF stock closing price Sep 21, 2018 (Closing)

The Acerus Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. Financials statements like the Acerus Pharma income statement and Acerus Pharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Acerus Pharma had cash and cash equivalents of $5.19M at beginning of the year and $3.15M at year end for 2017. Acerus Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Acerus Pharma saw a outflow of $- from investing activities for 2017.

View details of Acerus Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.99M2.16M2.38M2.56M1.16M1.13M-
Net Increase (Decrease) in Assets Liabilities5.68M5.5M-1.91M25.5M2.17M--
Cash From (used in) Discontinued Operations-------
Other Adjustments Net1.13M-15.57M7.53M3.01M1.13M2.76M5.64M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--0.07M-0.68M-0.21M-0.88M-0.13M-0.52M
Acquisition Disposition of Subsidiaires----41.41M---
Increase (Decrease) in Investments-------
Other Cash Inflow (Outflow) from Investment Activities------0.02M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-2M-24.87M41.52M11.78M31.08M
Issuance (Repayment) of Debt Securities-1.74M-5.78M-17M25.34M-2.75M6.91M2.4M
Increase (Decrease) in Bank & Other Borrowings-------
Payment of Dividends & Other Cash Distributions-------
Other Cash from (used by) Financing Activities-0.68M-0.68M-2.64M-2.11M-0.77M-0.74M-0.17M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---3.33M-2.04M-0.74M--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year5.19M6.33M31.01M18.11M9.21M14.52M-
Cash & Equivalents at Year End3.15M5.19M6.33M31.01M18.11M9.21M14.52M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Antares Pharma financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Acerus Pharma stock price history and Acerus Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Acerus Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Acerus Pharma stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Acerus Pharma lost $- cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $- for TRLPF stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between Acerus Pharma and its owners and creditors and was $-2.43M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Acerus Pharma Cash Flow

FCF margin